The importance of glomerular deposits of von Willebrand factor in human renal allografts

Renal Failure

Volumn 28, Issue 4, 2006, Pages 315-321

  Handan Ozdemir B ^a   Sar, Aylin ^a   Haberal, Mehmet ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Factor VIII RA; Glomerular sclerosis; Macrophage; Renal allograft; Transplantation; Von Willebrand factor

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; TACROLIMUS; VON WILLEBRAND FACTOR;

ARTICLE; CELL INFILTRATION; CHRONIC ALLOGRAFT NEPHROPATHY; FEMALE; GLOMERULOSCLEROSIS; GRAFT REJECTION; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACUTE DISEASE; ADOLESCENT; ADULT; BIOPSY; CELL COUNT; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; MACROPHAGES; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TRANSPLANTATION, HOMOLOGOUS; VON WILLEBRAND FACTOR;

EID: 33745566357     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220600577759     Document Type: Article

References (20)

1. Denton MD, Davis SF, Baum MA, Melter M, Reinders ME, Exeni A, Samsonov DV, Fang J, Ganz P, Briscoe DM. The role of the graft endothelium in transplant rejection: evidence that endothelial activation may serve as a clinical marker for the development of chronic rejection. Pediatr. Transplant 2000;4:252-260.
2. Ozdemir BH, Ozdemir FN, Gungen Y, Haberal M. Role of macrophages and lymphocytes in the induction of neovascularization in renal allograft rejection. Am. J. Kidney Dis. 2002;39:347-353.
3. Meyer D, Girma JP. von Willebrand factor: structure and function. Thromb. Hemost. 1993;70:99-104.
4. Wagner DD, Olmsted JB, Marder VJ. Immunolocalization of von Willebrand protein in Wiebel-Palade bodies of human endothelial cells. J. Cell Biol. 1982;95:355-360.
5. Sporn LA, Marder VJ, Wagner DD. Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell 1986;46:185-190.
6. Sato M, Koshikawa S, Arakawa M. Glomerular deposition of antihemophilic factor antigen in various renal diseases. Clin. Nephrol. 1981;15:80-86.
7. Lagoo AS, Buckley PJ, Burchell LJ, Peters D, Fechner JH, Tsuchida M, Dong Y, Hong X, Brunner KG, Oberley TD, Hamawy MM, Knechtle SJ. Increased glomerular deposits of von Willebrand factor in chronic, but not acute, rejection of primate renal allografts. Transplantation 2000;70:877-886.
8. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y, et al. The Banff 97 working classification of renal allografts pathology. Kidney Int. 1999;55:713-723.
9. Monga G, Mazzucco G, Novara R, Reale L. Intertubular capillary changes in kidney allografts: an ultrastructural study in patients with transplant glomerulopathy. Ultrastruct. Pathol. 1990;14:201-209.
10. Kiyici H, Demirhan B, Özdemir BH, Aktaş G, Karabay G, Haberal M. Significance of peritubular capillary basement membrane multilamellation in diagnosis of chronic allograft nephropathy. Transplant Proc. 2003;35:2643-2644.
11. Schlondorff D, Nelson PJ, Luckow B, Banas B. Chemokines and renal disease. Kidney Int. 1997;51:610-621.
12. Özdemir BH, Demirhan B, Gungen Y. The presence and prognostic importance of glomerular macrophage infiltration in renal allografts. Nephron. 2002;90:442-446.
13. Pichler R, Giachelli C, Young B, Alpers CE, Couser WG, Johnson RJ. The pathogenesis of tubulointerstitial disease associated with glomerulonephritis: the glomerular cytokine theory. Miner. Electrolyte Metab. 1995;21:317-327.
14. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. J. Leuk. Biol. 1994;55:410-422.
15. Floege J, Eng E, Young BA, Couser WG, Johnson RJ. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int. 1993;43:369-380.
16. Gradowska L, Lao M, Morzycka-Michalik M, Gorski A. Low dose heparin: efficacious treatment for chronic renal allograft rejection. Arch. Immunol Ther. Exp. (Warz) 1993;41:133-135.
17. Krzossok S, Birck R, Koeppel H, Schnulle P, Waldherr R, van der Wounde FJ, Braun C. Treatment of proteinuria with low-molecular weight heparin after renal transplantation. Transplant Int. 2004;17:468-472.
18. van der Pijl JW, van der Woude FJ, Geelhoed-Dujvestijn PH, Fröhlich M, van der Meer FJ, Lemkes HH, van Es LA. Danaparoid sodium lowers proteinuria in diabetic nephropathy. J. Am. Soc. Nephrol. 1997;8:456-462.
19. Ceol M, Vianello D, Schleicher E, Anglani F, Barbanti M, Bonfante L, Bertaglia G, Graziotto R, D'Angelo A, Del Prete D, Gambaro G. Heparin reduces glomerular infiltration and TGF-β protein expression by macrophages in puromycin glomerulosclerosis. J. Nephrol. 2003;16:210-218.
20. Braun C, Schultz M, Fang L, Schaub M, Back WE, Herr D, Laux V, Rohmeiss P, Schnuelle P, van der Woude FJ. Treatment of chronic renal allograft rejection in rats with a low-molecular weight heparin (Reviparin). Transplantation 2001;72:209-215.